April 2024
1. SHAH PL
   Ablation for lung cancer: hot or cold intervention.
   Thorax. 2024 Apr 4:thorax-2023-221369. doi: 10.1136/thorax-2023-221369.
   

   >> Share

   
   March 2024
2. JACOBS C
   Decoding pulmonary nodules: can machine learning enhance malignancy risk stratification?
   Thorax. 2024;79:293-294.
   

   >> Share

   
   
3. WARKENTIN MT, Al-Sawaihey H, Lam S, Liu G, et al
   Radiomics analysis to predict pulmonary nodule malignancy using machine learning approaches.
   Thorax. 2024;79:307-315.
   

   >> Share

   
   
4. ROSTOCK L, Holotiuk O, Ploenes T
   Well-differentiated papillary mesothelial tumour: a rare finding on the pleura.
   Thorax. 2024;79:380-381.
   

   >> Share

   
   February 2024
5. DAFFRE E, Porcher R, Iannelli A, Prieto M, et al
   Protective effect of height on long-term survival of resectable lung cancer: a new feature of the lung cancer paradox.
   Thorax. 2024 Feb 15:thorax-2023-220443. doi: 10.1136/thorax-2023-220443.
   

   >> Share

   
   
6. KOO MM, Mounce LTA, Rafiq M, Callister MEJ, et al
   Guideline concordance for timely chest imaging after new presentations of dyspnoea or haemoptysis in primary care: a retrospective cohort study.
   Thorax. 2024;79:236-244.
   

   >> Share

   
   January 2024
7. WONG JY, Blechter B, Hubbard AK, Machiela MJ, et al
   Phenotypic and genetically predicted leucocyte telomere length and lung cancer risk in the prospective UK Biobank.
   Thorax. 2024 Jan 17:thorax-2023-220076. doi: 10.1136/thorax-2023-220076.
   

   >> Share

   
   
8. SMITH P, Murray RL, Crosbie PA
   Integrated stop smoking interventions are essential to maximise the health benefits from lung cancer screening.
   Thorax. 2024 Jan 12:thorax-2023-221037. doi: 10.1136/thorax-2023-221037.
   

   >> Share

   
   
9. HICKMAN K
   Unmasking delays: bridging the gap in timely lung cancer diagnosis for UK primary care.
   Thorax. 2024 Jan 9:thorax-2023-220739. doi: 10.1136/thorax-2023-220739.
   

   >> Share

   
   December 2023
10. LI Y, Chen W, Xie F, Huang R, et al
    Novel electromagnetic navigation bronchoscopy system for the diagnosis of peripheral pulmonary nodules: a prospective, multicentre study.
    Thorax. 2023;78:1197-1205.
    

    >> Share

    
    November 2023
11. MORGAN H, Gysling S, Navani N, Baldwin D, et al
    Impact of the SARS-CoV-2 pandemic on lung cancer survival in England: an analysis of the rapid cancer registration dataset.
    Thorax. 2023 Nov 6:thorax-2022-219593. doi: 10.1136/thorax-2022-219593.
    

    >> Share

    
    October 2023
12. FIELD JK
    Road map to improve the quality of lung cancer risk data.
    Thorax. 2023 Oct 25:thorax-2023-220784. doi: 10.1136/thorax-2023-220784.
    

    >> Share

    
    
13. WILLIAMS PJ, Philip KEJ, Buttery SC, Perkins A, et al
    Immediate smoking cessation support during lung cancer screening: long-term outcomes from two randomised controlled trials.
    Thorax. 2023 Oct 24:thorax-2023-220367. doi: 10.1136/thorax-2023-220367.
    

    >> Share

    
    August 2023
14. GOODLEY P, Balata H, Alonso A, Brockelsby C, et al
    Invitation strategies and participation in a community-based lung cancer screening programme located in areas of high socioeconomic deprivation.
    Thorax. 2023 Aug 16:thorax-2023-220001. doi: 10.1136/thorax-2023-220001.
    

    >> Share

    
    July 2023
15. NG WWS, Chin K, Lam SM
    Rare cause of massive haemoptysis diagnosed by ultrasonography in the ICU.
    Thorax. 2023;78:733-734.
    

    >> Share

    
    
16. YOUNG RP, Ward RC, Scott RJ, Gamble GD, et al
    Airflow limitation and mortality during cancer screening in the National Lung Screening Trial: why quantifying airflow limitation matters.
    Thorax. 2023;78:690-697.
    

    >> Share

    
    June 2023
17. GRAU A, Lozano C, Gallego M
    Tracheal stenosis after endobronchial ultrasound-guided transbronchial needle aspiration.
    Thorax. 2023;78:631.
    

    >> Share

    
    April 2023
18. DAWSON AG, Kutywayo K, Mohammed SB, Fennell DA, et al
    Cytoreductive surgery with hyperthermic intrathoracic chemotherapy for malignant pleural mesothelioma: a systematic review.
    Thorax. 2023;78:409-417.
    

    >> Share

    
    March 2023
19. BRADLEY C, Boland A, Clarke L, Dallinson N, et al
    Diagnosis and treatment outcomes from prebronchodilator spirometry performed alongside lung cancer screening in a Lung Health Check programme.
    Thorax. 2023 Mar 27:thorax-2022-219683. doi: 10.1136/thorax-2022-219683.
    

    >> Share

    
    
20. RUPAREL M
    Lung cancer screening in advanced chronic obstructive pulmonary disease: helpful or harmful?
    Thorax. 2023 Mar 21:thorax-2022-219778. doi: 10.1136/thorax-2022-219778.
    

    >> Share

    
    
21. BENNETT K, Totton K, Misacas A, Caswell F, et al
    Transient visual loss following CT-guided percutaneous core needle biopsy of a lung lesion.
    Thorax. 2023;78:316-317.
    

    >> Share

    
    February 2023
22. CHAUHAN NK, Rajagopal R, Shadrach BJ, Dutt N, et al
    Pulmonary arterio-venous malformation on endobronchial ultrasound bronchoscopy.
    Thorax. 2023;78:214-215.
    

    >> Share

    
    January 2023
23. RUPAREL M
    Should we retain smaller growing nodules in lung cancer screening programmes for surveillance?
    Thorax. 2023 Jan 25:thorax-2022-219838. doi: 10.1136/thorax-2022-219838.
    

    >> Share

    
    
24. DU Y, Guo M, Wu Y, Wagner A, et al
    Lymphangioleiomyomatosis (LAM) Cell Atlas.
    Thorax. 2023;78:85-87.
    

    >> Share

    
    
25. CARUANA E, Steiner MC
    Perioperative rehabilitation in thoracic surgery: get up and go!
    Thorax. 2023;78:1-2.
    

    >> Share

    
    
26. KASSIRIAN S, Hinton SN, Cuninghame S, Chaudhary R, et al
    Diagnostic sensitivity of pleural fluid cytology in malignant pleural effusions: systematic review and meta-analysis.
    Thorax. 2023;78:32-40.
    

    >> Share

    
    December 2022
27. RAMOS-ESQUIVEL A
    Immunotherapy in non-small-cell lung cancer: new data support its use, but some challenges remain.
    Thorax. 2022;77:1159-1160.
    

    >> Share

    
    
28. VAN KOOTEN JP, Belderbos RA, von der Thusen JH, Aarts MJ, et al
    Incidence, treatment and survival of malignant pleural and peritoneal mesothelioma: a population-based study.
    Thorax. 2022;77:1260-1267.
    

    >> Share

    
    
29. KIDD AC, Anderson O, Cowell GW, Weir AJ, et al
    Fully automated volumetric measurement of malignant pleural mesothelioma by deep learning AI: validation and comparison with modified RECIST response criteria.
    Thorax. 2022;77:1251-1259.
    

    >> Share

    
    November 2022
30. CREAMER AW, Horst C, Dickson JL, Tisi S, et al
    Growing small solid nodules in lung cancer screening: safety and efficacy of a 200 mm(3) minimum size threshold for multidisciplinary team referral.
    Thorax. 2022 Nov 25:thorax-2022-219403. doi: 10.1136/thorax-2022-219403.
    

    >> Share

    
    
31. AZZOLINA D, Consonni D, Ferrante D, Mirabelli D, et al
    Rate advancement measurement for lung cancer and pleural mesothelioma in asbestos-exposed workers.
    Thorax. 2022 Nov 10. pii: thorax-2021-217862. doi: 10.1136/thorax-2021-217862.
    

    >> Share

    
    
32. WOZNITZA N, Ghimire B, Devaraj A, Janes SM, et al
    Impact of radiographer immediate reporting of X-rays of the chest from general practice on the lung cancer pathway (radioX): a randomised controlled trial.
    Thorax. 2022 Nov 8. pii: thorax-2022-219210. doi: 10.1136/thorax-2022-219210.
    

    >> Share

    
    
33. TANAKA H, Kabata H, Emoto K, Hayashi S, et al
    Young woman with multiple lung nodules: a pulmonary oxymoron.
    Thorax. 2022;77:1155-1157.
    

    >> Share

    
    October 2022
34. ROSE JA, Hunninghake GM
    Time to move out of the shadows: ILA in patients with lung cancer.
    Thorax. 2022 Oct 21. pii: thorax-2022-219498. doi: 10.1136/thorax-2022-219498.
    

    >> Share

    
    August 2022
35. HEWITT RJ, Bartlett EC, Ganatra R, Butt H, et al
    Lung cancer screening provides an opportunity for early diagnosis and treatment of interstitial lung disease.
    Thorax. 2022 Aug 8. pii: thorax-2022-219068. doi: 10.1136/thorax-2022-219068.
    

    >> Share

    
    July 2022
36. DICKSON JL, Hall H, Horst C, Tisi S, et al
    Telephone risk-based eligibility assessment for low-dose CT lung cancer screening.
    Thorax. 2022 Jul 21. pii: thoraxjnl-2021-218634.
    

    >> Share

    
    
37. ZHENG Y, Mao M, Li F, Wang L, et al
    Effects of enhanced recovery after surgery plus pulmonary rehabilitation on complications after video-assisted lung cancer surgery: a multicentre randomised controlled trial.
    Thorax. 2022 Jul 14. pii: thoraxjnl-2021-218183.
    

    >> Share

    
    June 2022
38. KANABAR SS, Tiwari A, Soran V, Balendran P, et al
    Impact of PD1 and PDL1 immunotherapy on non-small cell lung cancer outcomes: a systematic review.
    Thorax. 2022 Jun 10. pii: thoraxjnl-2020-215614.
    

    >> Share

    
    
39. IM Y, Chung MP, Lee KS, Han J, et al
    Impact of interstitial lung abnormalities on postoperative pulmonary complications and survival of lung cancer.
    Thorax. 2022 Jun 10. pii: thoraxjnl-2021-218055.
    

    >> Share

    
    May 2022
40. HESSEL PA
    Mesothelioma among vehicle mechanics: a controversy?
    Thorax. 2022;77:426-427.
    

    >> Share

    
    
41. THOMSEN RW, Riis AH, Flachs EM, Garabrant DH, et al
    Risk of asbestosis, mesothelioma, other lung disease or death among motor vehicle mechanics: a 45-year Danish cohort study.
    Thorax. 2022;77:477-485.
    

    >> Share

    
    April 2022
42. MORGAN H, Baldwin D, Hubbard R, Navani N, et al
    Ninety-day mortality following lung cancer surgery: outcomes from the English national clinical outcomes audit.
    Thorax. 2022 Apr 28. pii: thoraxjnl-2021-218308.
    

    >> Share

    
    
43. KLARENBEEK SE, Aarts MJ, van den Heuvel MM, Prokop M, et al
    Impact of time-to-treatment on survival for advanced non-small cell lung cancer patients in the Netherlands: a nationwide observational cohort study.
    Thorax. 2022 Apr 21. pii: thoraxjnl-2021-218059.
    

    >> Share

    
    March 2022
44. NAOI H, Suzuki Y, Mori K, Aono Y, et al
    Impact of antifibrotic therapy on lung cancer development in idiopathic pulmonary fibrosis.
    Thorax. 2022 Mar 30. pii: thoraxjnl-2021-218281.
    

    >> Share

    
    
45. NARAN R, Dattani V, Madani Y
    Lemierre's syndrome masking metastatic lung adenocarcinoma.
    Thorax. 2022;77:314-316.
    

    >> Share

    
    December 2021
46. LEEM G, Jeon M, Kim KW, Jeong S, et al
    Tumour-infiltrating bystander CD8(+) T cells activated by IL-15 contribute to tumour control in non-small cell lung cancer.
    Thorax. 2021 Dec 1. pii: thoraxjnl-2021-217001.
    

    >> Share

    
    November 2021
47. SHAMSEDDIN M, Obacz J, Garnett MJ, Rintoul RC, et al
    Use of preclinical models for malignant pleural mesothelioma.
    Thorax. 2021;76:1154-1162.
    

    >> Share

    
    October 2021
48. O'DOWD EL, Ten Haaf K, Kaur J, Duffy SW, et al
    Selection of eligible participants for screening for lung cancer using primary care data.
    Thorax. 2021 Oct 29. pii: thoraxjnl-2021-217142.
    

    >> Share

    
    
49. PERLEPE G, Kotsiou OS, Karetsi E, Papadopoulos D, et al
    Persistent consolidation: a MALT-easer.
    Thorax. 2021;76:1057-1059.
    

    >> Share

    
    
50. BARNES-HARRIS M, Allingham S, Morgan D, Ferreira D, et al
    Comparing functional decline and distress from symptoms in people with thoracic life-limiting illnesses: lung cancers and non-malignant end-stage respiratory diseases.
    Thorax. 2021;76:989-995.
    

    >> Share

    
    August 2021
51. GRAVIER FE, Smondack P, Prieur G, Medrinal C, et al
    Effects of exercise training in people with non-small cell lung cancer before lung resection: a systematic review and meta-analysis.
    Thorax. 2021 Aug 24. pii: thoraxjnl-2021-217242.
    

    >> Share

    
    
52. HALL H, Tocock A, Burdett S, Fisher D, et al
    Association between time-to-treatment and outcomes in non-small cell lung cancer: a systematic review.
    Thorax. 2021 Aug 17. pii: thoraxjnl-2021-216865.
    

    >> Share

    
    July 2021
53. ARAGHI M, Fidler-Benaoudia M, Arnold M, Rutherford M, et al
    International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
    Thorax. 2021 Jul 19. pii: thoraxjnl-2020-216555.
    

    >> Share

    
    June 2021
54. KRAMER T, Wijmans L, de Bruin M, van Leeuwen T, et al
    Bronchoscopic needle-based confocal laser endomicroscopy (nCLE) as a real-time detection tool for peripheral lung cancer.
    Thorax. 2021 Jun 25. pii: thoraxjnl-2021-216885.
    

    >> Share

    
    May 2021
55. ZENG L, Xu Q, Yang N, Lizaso A, et al
    Third left pulmonary lobe.
    Thorax. 2021;76:525.
    

    >> Share

    
    April 2021
56. NASR E, MacRae S, Dobson M, Russell D, et al
    A rare condition masquerading as lung cancer.
    Thorax. 2021 Apr 26. pii: thoraxjnl-2020-216689.
    

    >> Share

    
    
57. VISSER S, Koolen S, van Donk N, van Walree N, et al
    Genetic polymorphism in ATIC is associated with effectiveness and toxicity of pemetrexed in non-small-cell lung cancer.
    Thorax. 2021 Apr 15. pii: thoraxjnl-2020-216504.
    

    >> Share

    
    
58. KIM YW, Kwon BS, Lim SY, Lee YJ, et al
    Lung cancer probability and clinical outcomes of baseline and new subsolid nodules detected on low-dose CT screening.
    Thorax. 2021 Apr 15. pii: thoraxjnl-2020-215107.
    

    >> Share

    
    February 2021
59. TAN VSR, Li A, Seet JE, Lee P, et al
    Metastases from tracheal adenoid cystic carcinoma.
    Thorax. 2021;76:208-209.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share